According to the latest report published by Credence Research, Inc. “Orthopedic Oncology Treatment Market
(Treatment Type: Soft Tissue Excisions/Resections, Limb Salvage
Surgery, Amputations, Adjuvant Chemotherapy, Reconstructive Surgery):
Growth, Future Prospects and Competitive Analysis,
2016-2022,” the orthopedic oncology treatment market was valued at USD
1.02 Bn in 2015, and is expected to reach USD 1.12 Mn by 2023, expanding
at a CAGR of 1.2% from 2016 to 2023.
Browse the full report Orthopedic Oncology Treatment: Market Growth, Future Prospects and Competitive Analysis, 2016-2023 at http://www.credenceresearch.com/report/orthopedic-oncology-treatment-market
Market Insights
While the management of musculoskeletal
sarcoma remains one of the most significant challenges in oncology,
there have been prominent improvements in the past decades. Improvement
in surgical systems, nature of implants, imaging modalities, adjuvant
chemotherapy have improved the treatment output to such an extent that
currently 2/3rds of musculoskeletal carcinoma patients are anticipated
to be long-term disease survivors and several will successfully benefit
from limb salvage procedures. the field of orthopedic oncology continues
to be invigorated by exhilarating research and developments that has
enhanced the level of treatment and care of patients with various bone
and soft-tissue tumors. Currently, most patients with primary bone
sarcomas are offered limb salvage surgery without increasing the risk of
survival at the sarcoma centers. Moreover, the advances in the imaging
technique and surgical techniques have further improved the treatment of
patients with bone and soft-tissue malignancies. Orthopedic oncologists
continue to join forces with other sub-specialists to integrate
advances in surgical techniques. This is especially true for the
development of implants and image guided surgery.
Request Free Sample of This Report @ http://www.credenceresearch.com/sample-request/58181
The global orthopedic oncology treatment
market on type of procedures has been segmented into soft tissue
excisions/resections, limb salvage surgery, amputation, adjuvant
chemotherapy and reconstructive surgery. The reconstructive surgery is
further sub-segmented into hip & joint replacement and bone grafts.
The reconstructive surgery has the largest share in the global
orthopedic oncology treatment market. The bone grafting techniques is
anticipated to grow at the highest rate during the forecast period owing
to the advances in the field of prosthesis and endoprosthesis. In the
base 2015, Asia Pacific was observed as the largest market for
orthopedic oncology market. Large disease prevalence along with the
growing healthcare ecosystem in the region has assisted the growth of
the orthopedic oncology market in Asia-Pacific. Moreover, growth in the
medical tourism in the region in the last decade has further fueled the
market for orthopedic oncology treatment market in Asia-Pacific.
The major players operating in this
market include Stryker Corporation, DePuy Synthes, Zimmer Biomet,
Sanofi, Roche Holdings and others.
About Us
Credence Research is a worldwide market
research and counseling firm that serves driving organizations,
governments, non legislative associations, and not-for-benefits. We
offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over
almost a century, we’ve manufactured a firm extraordinarily prepared to
this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: +1-800-361-8290
Website: http://www.credenceresearch.com
No comments:
Post a Comment